Regency-Logo2012-RGB.jpg
Regency Centers Releases Annual Corporate Responsibility Report for 2023
May 16, 2024 08:15 ET | Regency Centers Corporation
JACKSONVILLE, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency”, “Regency Centers” or the “Company”) (Nasdaq:REG) today released its 2023 Corporate Responsibility Report...
Picture1.png
Imperial Petroleum Inc. Reports First Quarter 2024 Financial and Operating Results
May 16, 2024 08:15 ET | Imperial Petroleum Inc.
ATHENS, Greece, May 16, 2024 (GLOBE NEWSWIRE) -- IMPERIAL PETROLEUM INC. (NASDAQ: IMPP, the “Company”), a ship-owning company providing petroleum products, crude oil and drybulk seaborne...
orion.png
LED Lighting and EV Charging Solutions Provider Orion Previews FY 2024 Results in Anticipation of its Singular Research Webinar Presentation Wed. May 22 at 3pm ET
May 16, 2024 08:05 ET | Orion Energy Systems, Inc.
LED Lighting and EV Charging Solutions Provider Orion Previews FY 2024 Results Ahead of its Singular Research Webinar Presentation, Wed. 5/22 at 3pm ET.
NKGen Biotech RGB.jpg
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition
May 16, 2024 08:05 ET | NKGen Biotech, Inc.
SANTA ANA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and...
Ardelyx-Logo-RGB.png
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
May 16, 2024 08:01 ET | Ardelyx, Inc.
WALTHAM, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class...
Xcel_Black PNG.png
Xcel Brands to Host First Quarter 2024 Earnings Call on May 20
May 16, 2024 08:01 ET | Xcel Brands, Inc
NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), today announced that it will report its first quarter 2024 financial results on May 20, 2024....
Picture2
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
May 16, 2024 08:01 ET | Ocean Biomedical, Inc.
Providence, RI, May 16, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been granted a new patent for his malaria...
fortressbio1.jpg
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
May 16, 2024 08:00 ET | Fortress Biotech, Inc.
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...
ALGM Logo(July2023).jpg
Allegro MicroSystems to Present at TD Cowen’s Technology, Media & Telecom Conference on May 29
May 16, 2024 08:00 ET | Allegro MicroSystems, Inc.
Manchester, N.H., May 16, 2024 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy...
Akari Logo (1).jpg
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
May 16, 2024 08:00 ET | Akari Therapeutics Plc
Entered into a Definitive Merger Agreement with Peak Bio; Expected to Close in the Third Quarter of 2024 Samir R. Patel, M.D. Appointed Interim CEO Plan for Prioritization of Peak Bio’s ADC Cancer...